What margins are necessary for incorporating mediastinal nodal mobility into involved-field radiotherapy for lung cancer?
- 1 August 2002
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 53 (5) , 1211-1215
- https://doi.org/10.1016/s0360-3016(02)02853-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Interim analysis of a phase I/II dose escalation trial in non-small cell lung cancer (NSCLC) using three-dimensional conformal radiotherapy (3D-CRT)International Journal of Radiation Oncology*Biology*Physics, 2001
- Can elective nodal irradiation be omitted in stage III non-small cell lung cancer? An analysis of recurrences after sequential chemotherapy and “involved-field” radiotherapy to 70 gyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Multiple “slow” CT scans for incorporating lung tumor mobility in radiotheraphy planningInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Elective nodal irradiation in the treatment of non–small-cell lung cancer with three-dimensional conformal radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Analysis and reduction of 3D systematic and random setup errors during the simulation and treatment of lung cancer patients with CT-based external beam radiotherapy dose planningInternational Journal of Radiation Oncology*Biology*Physics, 2001
- Dose Escalation in Non–Small-Cell Lung Cancer Using Three-Dimensional Conformal Radiation Therapy: Update of a Phase I TrialJournal of Clinical Oncology, 2001
- Counterpoint: Better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiationSeminars in Radiation Oncology, 2000
- The location of recurrences in patients with non-small cell lungcancer treated with involved-field irradiationLung Cancer, 2000
- Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1992